MENU
HTEC
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

HTEC stock forecast, quote, news & analysis

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
HTEC
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for HTEC with price predictions
Oct 05, 2026

HTEC's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for HTEC turned positive on September 22, 2026. Looking at past instances where HTEC's MACD turned positive, the stock continued to rise in 51 of 56 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 21, 2026. You may want to consider a long position or call options on HTEC as a result. In 76 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.

Following a +2.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where HTEC advanced for three days, in 261 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

HTEC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 193 of 233 cases where HTEC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

Bearish Trend Analysis

The 10-day RSI Indicator for HTEC moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 35 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 61 of 70 cases where HTEC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HTEC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Bristol-Myers Squibb Co (NYSE:BMY), Moderna (NASDAQ:MRNA), Regeneron Pharmaceuticals (NASDAQ:REGN), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Incyte Corp (NASDAQ:INCY).

Industry description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies’ products and services. It is non-diversified.

Market Cap

The average market capitalization across the ROBO Global Healthcare Technology and Innovation ETF (HTEC) ETF is 33.59B. The market cap for tickers in the group ranges from 1.12B to 250.91B. TMO holds the highest valuation in this group at 250.91B. The lowest valued company is AORT at 1.12B.

High and low price notable news

The average weekly price growth across all stocks in the ROBO Global Healthcare Technology and Innovation ETF (HTEC) ETF was 19%. For the same ETF, the average monthly price growth was 79%, and the average quarterly price growth was 282%. GRAL experienced the highest price growth at 16%, while IART experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the ROBO Global Healthcare Technology and Innovation ETF (HTEC) ETF was 16%. For the same stocks of the ETF, the average monthly volume growth was 61% and the average quarterly volume growth was 7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 49
Price Growth Rating: 47
SMR Rating: 72
Profit Risk Rating: 86
Seasonality Score: 27 (-100 ... +100)
HTEC's MACD Histogram crosses above signal line